WATSON 841 (Bisoprolol fumarate and hydrochlorothiazide 2.5 mg / 6.25 mg)
Pill imprint WATSON 841 has been identified as Bisoprolol fumarate and hydrochlorothiazide 2.5 mg / 6.25 mg.
Bisoprolol/hydrochlorothiazide is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy. Bisoprolol/hydrochlorothiazide 2.5 mg / 6.25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 841 (Bisoprolol fumarate and hydrochlorothiazide 2.5 mg / 6.25 mg)
- 2.5 mg / 6.25 mg
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
dibasic calcium phosphate
|NDC Code||Manufacturer / Repackager|
|00490-0053||Southwood Pharmaceuticals Inc (repackager)|
|23490-7861||Palmetto State Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.
More about bisoprolol/hydrochlorothiazide
- Hydrochlorothiazide and bisoprolol
- Bisoprolol and hydrochlorothiazide (Advanced Reading)
- Other brands: Ziac